<DOC>
	<DOCNO>NCT02087904</DOCNO>
	<brief_summary>A Phase 2a , multicenter , randomize , double-blind , parallel group , placebo-controlled study evaluate safety , tolerability , efficacy pharmacokinetic/pharmacodynamic effect ABT-981 patient symptomatic , radiographic , inflammatory knee osteoarthritis .</brief_summary>
	<brief_title>A Phase 2a Study Evaluating Safety , Efficacy , Pharmacodynamic Effects ABT-981 Patients With Knee Osteoarthritis</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<criteria>1 . Radiographic knee osteoarthritis KellgrenLawrence Grade 2 3 2 . Body Mass Index ( BMI ) 1834 kg/m2 3 . One clinical sign symptom active inflammation index knee 1 . History allergic reaction constituent study drug , Immunoglobulin G ( IgG ) contain product 2 . History anaphylactic reaction agent 3 . Significant trauma surgery index knee 3 . Severe knee malalignment 4 . Any uncontrolled medical illness unstable treatment therapy</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>74 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Pain</keyword>
	<keyword>Osteoarthritis</keyword>
	<keyword>Synovitis</keyword>
	<keyword>Knee</keyword>
</DOC>